Surya Wahyu, Li Yan, Verdià-Bàguena Carmina, Aguilella Vicente M, Torres Jaume
School of Biological Sciences, Nanyang Technological University, Singapore.
Department of Physics, Laboratory of Molecular Biophysics, Universitat Jaume I, 12071 Castellón, Spain.
Virus Res. 2015 Apr 2;201:61-6. doi: 10.1016/j.virusres.2015.02.023. Epub 2015 Feb 27.
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly identified pathogen able of human transmission that causes a mortality of almost 40%. As in the case of SARS-CoV, MERS virus lacking E protein represents a potential vaccine. In both cases, abolishment of channel activity may be a contributor to the attenuation observed in E-deleted viruses. Herein, we report that purified MERS-CoV E protein, like SARS-CoV E protein, is almost fully α-helical, has a single α-helical transmembrane domain, and forms pentameric ion channels in lipid bilayers. Based on these similarities, and the proposed involvement of channel activity as virulence factor in SARS-CoV E protein, MERS-CoV E protein may constitute a potential drug target.
中东呼吸综合征冠状病毒(MERS-CoV)是一种新发现的可在人际间传播的病原体,其致死率近40%。与严重急性呼吸综合征冠状病毒(SARS-CoV)的情况一样,缺乏E蛋白的MERS病毒是一种潜在的疫苗。在这两种情况下,通道活性的丧失可能是E蛋白缺失病毒中观察到的减毒的一个因素。在此,我们报告纯化的MERS-CoV E蛋白与SARS-CoV E蛋白一样,几乎完全呈α螺旋结构,有一个单一的α螺旋跨膜结构域,并在脂质双层中形成五聚体离子通道。基于这些相似性,以及通道活性作为SARS-CoV E蛋白毒力因子的推测,MERS-CoV E蛋白可能构成一个潜在的药物靶点。